Literature DB >> 2330532

Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus.

L M Tang1.   

Abstract

Fourteen patients with cryptococcal meningitis were reviewed. All patients had a ventriculoperitoneal shunt for hydrocephalus. Early recognitions and prompt relief of hydrocephalus were useful for eight patients who showed rapid deterioration of consciousness or signs of cerebral herniation. There was no surgical response in four patients who had had weeks of confusion or mental change. It seems, therefore, that the duration of disturbance of consciousness or change of mentality before shunting is critical in determination of the outcome of the treatment. Ventricular shunting was effective in relieving papilledema in five patients. However, the surgery did not prevent the development of papilledema to optic atrophy and subsequent blindness in two patients. Hence, in addition to hydrocephalus with increased intracranial pressure, conditions such as direct invasion of the optic pathways by Cryptococcus neoformans or optochiasmatic arachnoiditis may be responsible for the visual failure. Ventricular shunting was also helpful in restoring paraparesis in one patient. Of the cerebrospinal fluid determinations, low protein concentration was a favorable indicator for surgery. Of the seven patients who received the surgical procedure before the start of antifungal therapy, four showed a significant improvement despite active infection of the central nervous system. None of the seven patients deteriorated because of the surgical operation. Thus, active stage of cryptococcal meningitis does not contraindicate the necessity of shunting, and premedication with antifungal drugs is unnecessary. Also, no shunt-related morbidity and mortality was seen in this study.

Entities:  

Mesh:

Year:  1990        PMID: 2330532     DOI: 10.1016/0090-3019(90)90198-x

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  8 in total

1.  Pseudotumour cerebri syndrome due to cryptococcal meningitis.

Authors:  P D Cremer; I H Johnston; G M Halmagyi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

2.  Effects of pentoxifylline or dexamethasone in combination with amphotericin B in experimental murine cerebral cryptococcosis: evidence of neuroexcitatory pathogenic mechanisms.

Authors:  L Ostrosky-Zeichner; J L Soto-Hernandez; V Angeles-Morales; F Teixeira; C Nava-Ruiz; C Rios; F Solis; J Sotelo
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications.

Authors:  D A Stevens; D W Denning; S Shatsky; R W Armstrong; J D Adler; B H Lewis
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

4.  Cryptococcal meningitis causing obstructive hydrocephalus in a patient on fingolimod.

Authors:  Chengde Pham; Iwan Bennett; Rondhir Jithoo
Journal:  BMJ Case Rep       Date:  2017-07-06

Review 5.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

6.  Cryptococcal meningitis manifesting as a large abdominal cyst in a HIV-infected patient with a CD4 count greater than 400 cells/mm(3).

Authors:  Nancy Crum-Cianflone; April Truett; Mark R Wallace
Journal:  AIDS Patient Care STDS       Date:  2008-05       Impact factor: 5.078

7.  Treatment of indolent, nonencapsulated cryptococcal meningitis associated with hydrocephalus.

Authors:  Sarah T Garber; Paul L Penar
Journal:  Clin Pract       Date:  2012-01-27

8.  Diagnostic Challenges of Cryptococcus neoformans in an Immunocompetent Individual Masquerading as Chronic Hydrocephalus.

Authors:  Kedar R Mahajan; Amity L Roberts; Mark T Curtis; Danielle Fortuna; Robin Dharia; Lori Sheehan
Journal:  Case Rep Neurol Med       Date:  2016-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.